Answer:
The potential risks associated with plant-based pharmaceuticals include: pollen transfer to related species, contamination of non-transgenic crops intended for the consumption by humans, allergic reactions to the drugs produced from the genetically engineered plant, and persistence of genetically engineered material to persist in the environment and accumulate in non-target organisms. Risk assessment of plant-made pharmaceuticals should be reviewed on a case-by-case basis because the plants used to produce proteins each have different risks associated with them.
Survivorship curve = so, first of all, it's a curve, as in a graph.
It describes "survivorship" - the rate of survival, in other words: out of 100 organisms that are born, how many survive. This rate is different among species, for example, most humans live out to most of their life span, and almost all can survive well beyond a reproductive age.
However, in frogs for example, many many individuals are born, but only few can survive to adulthood: most die very young, before reproductive age.
So if you hear about a new species: let's say dogs, and you want to know how long they would live, you would look at their sirvivorship curve (and in some breeds of dogs, those that are likely not to be in shelters, but in homes, the survivorship curve would be similar as in humans: almost all individuals born can live long.
RUBISCO!
Ribulose-1,5-bisphosphate carboxylase/oxygenase
